Log in to save to my catalogue

Analysis of minimal residual disease by Ig/TCR gene rearrangements: guidelines for interpretation of...

Analysis of minimal residual disease by Ig/TCR gene rearrangements: guidelines for interpretation of...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_817602556

Analysis of minimal residual disease by Ig/TCR gene rearrangements: guidelines for interpretation of real-time quantitative PCR data

About this item

Full title

Analysis of minimal residual disease by Ig/TCR gene rearrangements: guidelines for interpretation of real-time quantitative PCR data

Publisher

London: Nature Publishing Group UK

Journal title

Leukemia, 2007-04, Vol.21 (4), p.604-611

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Most modern treatment protocols for acute lymphoblastic leukaemia (ALL) include the analysis of minimal residual disease (MRD). To ensure comparable MRD results between different MRD-polymerase chain reaction (PCR) laboratories, standardization and quality control are essential. The European Study Group on MRD detection in ALL (ESG-MRD-ALL), consis...

Alternative Titles

Full title

Analysis of minimal residual disease by Ig/TCR gene rearrangements: guidelines for interpretation of real-time quantitative PCR data

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_817602556

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_817602556

Other Identifiers

ISSN

0887-6924

E-ISSN

1476-5551

DOI

10.1038/sj.leu.2404586

How to access this item